Jennifer A. Zambriski

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis

Ujjini H. Manjunatha, Sumiti Vinayak, Jennifer A. Zambriski et al. · Nature · 2017 · 191 citations · Full text

Pharmacology, Medicine, Pathology +1

Development of an Orally Available and Central Nervous System (CNS) Penetrant <i>Toxoplasma gondii</i> Calcium-Dependent Protein Kinase 1 (<i>Tg</i>CDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of <i>Toxoplasmosis</i>

Rama Subba Rao Vidadala, Kasey Rivas, Kayode K. Ojo et al. · Journal of Medicinal Chemistry · 2016 · 96 citations · Full text

Immunology, Pathology, Cell Death +17

Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis

Deborah A. Schaefer, Dana P. Betzer, Kylie D. Smith et al. · The Journal of Infectious Diseases · 2016 · 70 citations · Full text

Parasitic Disease, Antiparasitic Agent, Medicine +12

Microbiome sharing between children, livestock and household surfaces in western Kenya

Emily Mosites, Matt Sammons, Elkanah Otiang et al. · PLoS ONE · 2017 · 66 citations · Full text

Nutrition, Dysbiosis, Household Surfaces +17

A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box

Rajiv S. Jumani, Kovi Bessoff, Melissa S. Love et al. · Antimicrobial Agents and Chemotherapy · 2018 · 65 citations · Full text